Search research articles
Contact Us
Filters
Showing results (1-10 of 180) with videos related to
Page
of 18
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
Molecular profiling and commercial predication assays in ovarian cancer: still not ready for prime time?
Elise C Kohn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2015
To Treat or Not to Treat: The Use of Hormone Replacement Therapy in Patients With Ovarian Cancer
Stanley Lipkowitz, Elise C Kohn
Clinical & Experimental Metastasis
|
June 18, 2002
Signal transduction targets in invasion
Riccardo Alessandro, Elise C Kohn
Cancer
|
December 13, 2012
Ovarian cancer : making its own rules-again
Elise C Kohn, Jean Hurteau
JAMA Oncology
|
March 22, 2019
Disease Labels and Clear Communication With Patients-A Rose by Any Other Name Would Smell as Sweet
Elise C Kohn, Shakun Malik
Cancer
|
June 26, 2015
Does one size fit all? The updated ovarian cancer staging: Still a work in progress
Linda R Duska, Elise C Kohn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2022
Biomarker Development: Bedside to Bench
Grace E Mishkin, Elise C Kohn
Nature Genetics
|
January 2, 2003
Cancer's deadly signature
Lance A Liotta, Elise C Kohn
Frontiers in Oncology
|
May 21, 2016
Confronting the Care Delivery Challenges Arising from Precision Medicine
Elise C Kohn, S Percy Ivy
Oncology (Williston Park, N.Y.)
|
April 17, 2017
PARP Inhibitors: The Cornerstone of DNA Repair-Targeted Therapies
Jaydira del Rivero, Elise C Kohn
Page
of 18
Search research articles
Search
Showing results (1-10 of 180) with videos related to
Sort By:
Page
of 18
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
Molecular profiling and commercial predication assays in ovarian cancer: still not ready for prime time?
Elise C Kohn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2015
To Treat or Not to Treat: The Use of Hormone Replacement Therapy in Patients With Ovarian Cancer
Stanley Lipkowitz, Elise C Kohn
Clinical & Experimental Metastasis
|
June 18, 2002
Signal transduction targets in invasion
Riccardo Alessandro, Elise C Kohn
Cancer
|
December 13, 2012
Ovarian cancer : making its own rules-again
Elise C Kohn, Jean Hurteau
JAMA Oncology
|
March 22, 2019
Disease Labels and Clear Communication With Patients-A Rose by Any Other Name Would Smell as Sweet
Elise C Kohn, Shakun Malik
Cancer
|
June 26, 2015
Does one size fit all? The updated ovarian cancer staging: Still a work in progress
Linda R Duska, Elise C Kohn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2022
Biomarker Development: Bedside to Bench
Grace E Mishkin, Elise C Kohn
Nature Genetics
|
January 2, 2003
Cancer's deadly signature
Lance A Liotta, Elise C Kohn
Frontiers in Oncology
|
May 21, 2016
Confronting the Care Delivery Challenges Arising from Precision Medicine
Elise C Kohn, S Percy Ivy
Oncology (Williston Park, N.Y.)
|
April 17, 2017
PARP Inhibitors: The Cornerstone of DNA Repair-Targeted Therapies
Jaydira del Rivero, Elise C Kohn
Page
of 18